Redwood City, CA, United States of America

Bruce Andrew Kowalczyk

USPTO Granted Patents = 8 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Cupertino, CA (US) (1996)
  • Palo Alto, CA (US) (1996)
  • Redwood City, CA (US) (2001 - 2006)

Company Filing History:


Years Active: 1996-2006

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Bruce Andrew Kowalczyk: Innovator in Pharmaceutical Chemistry

Introduction

Bruce Andrew Kowalczyk is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work primarily focuses on the development of innovative therapeutic agents.

Latest Patents

Among his latest patents, Kowalczyk has developed 2-(substituted-phenyl)amino-imidazoline derivatives. This invention relates to IP receptor antagonists selected from a group of compounds represented by a specific formula, including various substituents as defined in the specification. These compounds, along with their pharmaceutically acceptable salts or crystal forms, are integral to pharmaceutical compositions and methods for their use as therapeutic agents.

Career Highlights

Throughout his career, Kowalczyk has worked with prominent companies, including Syntex (U.S.A.) Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of new therapeutic solutions.

Collaborations

Kowalczyk has collaborated with notable coworkers, including Keith Roger Bley and Robin D. Clark. These partnerships have played a crucial role in advancing his research and patent developments.

Conclusion

Bruce Andrew Kowalczyk is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in therapeutic agents. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…